## Core Concept
Neuroblastoma is a type of cancer that primarily affects children and originates from the neural crest cells, which are precursors to the sympathetic nervous system. It is most commonly found in the adrenal glands but can also arise in other locations along the sympathetic nervous system chain. The clinical behavior of neuroblastoma can vary widely, ranging from spontaneous regression to aggressive disease.

## Why the Correct Answer is Right
The correct answer, although not directly provided, relates to specific characteristics of neuroblastoma. Typically, characteristics of neuroblastoma include:
- It is a tumor of the adrenal glands or, less commonly, of the sympathetic nervous system.
- It often presents in children under the age of 5.
- The tumor can cause a variety of symptoms depending on its location, including abdominal distension, bone pain, or even opsoclonus-myoclonus syndrome.

## Why Each Wrong Option is Incorrect
Without specific details on options A, B, C, and D, a general approach to evaluating incorrect options regarding neuroblastoma:
- **Option A:** If this option suggests a common adult cancer, it would be incorrect because neuroblastoma is primarily a pediatric cancer.
- **Option B:** If this option provides an incorrect age range for typical presentation, it would be incorrect as neuroblastoma primarily affects infants and young children.
- **Option C:** If this option describes a different type of cancer or an incorrect characteristic of neuroblastoma, it would be incorrect based on the specific details provided.
- **Option D:** Similarly, if this option does not align with known facts about neuroblastoma, such as its origin, common sites, or clinical features, it would be incorrect.

## Clinical Pearl / High-Yield Fact
A key point to remember about neuroblastoma is its potential for spontaneous regression, particularly in infants. This characteristic makes the management and prognosis of neuroblastoma highly variable and age-dependent. Additionally, certain genetic features, such as amplification of the MYCN oncogene, are associated with a worse prognosis.

## Correct Answer: D.